AUTL
Autolus Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.26 / 10
Outperform
Analyst consensus is 100% Strong Buy, with a 6.93 weighted rating and 100% historical win rate. Fund‑flow score is 7.6/10, showing solid inflows despite negative trends, supporting a bullish sentiment.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-17
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for AUTL?
- AUTL holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.26/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
